Delcath Systems (DCTH)announced that it has satisfied all of the requirements to affix the CE Mark to its Hepatic CHEMOSAT Delivery System for use with doxorubicin hydrochloride injection. http://finance.yahoo.com/news/delcath-announces-ce-marking-hepatic-103101254.html